Journal of Geriatric Psychiatry and Neurology

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Free Access - Register Here

Click here to sign up for SAGE Journal Email Alerts today!

Sign In to gain access to subscriptions and/or personal tools.
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Terry, R. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Terry, R. D.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
Journal of Geriatric Psychiatry and Neurology, Vol. 19, No. 3, 125-128 (2006)
DOI: 10.1177/0891988706291079

Alzheimer’s Disease and the Aging Brain

Robert D. Terry, MD

Department of Neurosciences, University of California, San Diego, rterry{at}ucsd.edu

The frequencies of each of the several types of dementia are enumerated, showing that Alzheimer’s disease is present in about 80% of cases. Cerebral changes associated with cognitively normal aging include shrinkage of large cortical neurons but not a significant loss of total neuronal number. Nevertheless, the population density of synapses measured by confocal microscopy does decline significantly in normal aging. The classical lesions of Alzheimer’s disease are neuritic plaques and neurofibrillary tangles, and their frequency correlates with declining cognitive measures. Although amyloid is prominent in plaques, it is probably not the agent of destruction. That role seems to be held by Aß oligomers. The strongest structural correlate with cognitive tests is synapse loss, which is probably caused by Aß oligopeptides in the terminal axons and dendrites. (J Geriatr Psychiatry Neurol 2006;19:125-128)

Key Words: Alzheimer’s disease • neuritic plaques • neurofibrillary tangles • autopsy • amyloid peptide


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?